IP assets in the Life Sciences

For early-stage pharma and biotech companies, comprehensive intellectual property (IP) strategies do more than protect innovation. They set the stage for your company’s long-term success – helping raise funds, attract partners and expand into new markets.

Our Vancouver IP Group has created a three-part video series to provide early-stage life sciences companies with the resources they need to ensure their IP assets are protected in a highly competitive market.

In this video, Mark Wilke, partner and patent agent, gives an introduction into the various IP assets – patents, industrial designs/design patents, trademarks, copyrights and trade secrets – that are fundamental for life sciences companies.

This video may contain information of general interest about current legal issues, but does not give legal advice.